# Safety Alert: Cannabis Gummies Recalled for Unlabeled Soy Content > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-gummies-recall-unlabeled-soy/ > **Published:** 2026-10-11T11:00:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-17T15:57:15-04:00 > **Clinical Summary:** Cannabis gummies recall unlabeled soy highlights a critical patient safety issue for those with soy allergies. This recall underscores the importance of quality --- ✦ New CED Clinical Relevance  #92High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Product SafetyFood AllergiesQuality ControlRegulationPatient Safety Why This Matters Food allergen contamination in cannabis products represents a serious patient safety concern, particularly for patients with severe soy allergies who may experience anaphylaxis. This recall highlights the ongoing quality control challenges in cannabis manufacturing that can directly impact patient safety and treatment outcomes. Clinical Summary Cannabis gummies have been recalled due to undisclosed soy content, creating potential exposure risk for patients with soy allergies. This represents a failure in ingredient labeling and quality assurance processes. For patients with soy sensitivity or allergy, exposure could range from mild gastrointestinal symptoms to severe allergic reactions. The incident underscores the importance of rigorous manufacturing standards and complete ingredient disclosure in cannabis products used medicinally. Dr. Caplan’s Take “This is exactly why I counsel patients to source cannabis products from licensed dispensaries with robust testing requirements rather than unregulated markets. When we’re treating medical conditions with cannabis, product purity and accurate labeling aren’t luxuries—they’re clinical necessities.” Clinical Perspective 🧠 Clinicians should routinely inquire about food allergies when recommending cannabis products and advise patients to carefully review all ingredient lists. Patients with known food allergies should be counseled to purchase only from licensed dispensaries with comprehensive testing and labeling standards. This incident reinforces the need for medical-grade quality assurance in therapeutic cannabis products. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Safety%20Alert%3A%20Cannabis%20gummies%20recalled%20for%20unlabeled%20soy%20-%20FOX19%20%40drcaplan&url=https%3A//www.fox19.com/video/2026/04/16/safety-alert-cannabis-gummies-recalled-unlabeled-soy/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.fox19.com/video/2026/04/16/safety-alert-cannabis-gummies-recalled-unlabeled-soy/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Safety%20Alert%3A%20Cannabis%20gummies%20recalled%20for%20unlabeled%20soy%20-%20FOX19%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.fox19.com/video/2026/04/16/safety-alert-cannabis-gummies-recalled-unlabeled-soy/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.fox19.com/video/2026/04/16/safety-alert-cannabis-gummies-recalled-unlabeled-soy/](https://www.fox19.com/video/2026/04/16/safety-alert-cannabis-gummies-recalled-unlabeled-soy/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance of this cannabis news?](#What_is_the_clinical_relevance_of_this_cannabis_news) - [What are the main safety concerns addressed in this article?](#What_are_the_main_safety_concerns_addressed_in_this_article) - [How do food allergies relate to cannabis products?](#How_do_food_allergies_relate_to_cannabis_products) - [What quality control measures are discussed?](#What_quality_control_measures_are_discussed) - [What regulatory aspects are covered?](#What_regulatory_aspects_are_covered) - [Related](#Related) ## FAQ #### What is the clinical relevance of this cannabis news? This article has been rated as having high clinical relevance (#92) by CED Clinical standards. It presents strong evidence or policy relevance with direct clinical implications for healthcare providers and patients. #### What are the main safety concerns addressed in this article? The article focuses on product safety issues within cannabis products. It also addresses quality control measures and regulatory compliance that impact patient safety. #### How do food allergies relate to cannabis products? Cannabis products may contain allergens or be processed in facilities that handle common allergens. Patients with food allergies should be aware of potential cross-contamination risks and ingredient lists in cannabis products. #### What quality control measures are discussed? The article examines quality control standards for cannabis products to ensure consistency and safety. These measures are essential for maintaining therapeutic efficacy and preventing adverse reactions in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients. #### What regulatory aspects are covered? The article discusses current regulations governing [cannabis product safety](https://cedclinic.com/adult-use-cannabis-pilot-program-louisiana-advances/) and quality standards. These regulations help ensure that [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) meet safety requirements and provide reliable therapeutic outcomes for patients. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis edibles sold in Ohio recalled – FOX 8 News](https://cedclinic.com/cannabis-edibles-sold-in-ohio-recalled-fox-8-news/) Explore details on recent cannabis edible recalls in Ohio and their implications for patient safety and regulatory compliance. [Read More](https://cedclinic.com/cannabis-edibles-sold-in-ohio-recalled-fox-8-news/) [Arizona health officials recall marijuana preroll over possible fungal contamination](https://cedclinic.com/arizona-health-officials-recall-marijuana-preroll-over-possible-fungal-contamination/) Learn about a marijuana preroll recall due to fungal contamination and its impact on [consumer safety](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) and [product quality](https://cedclinic.com/cannabis-production-equipment-lens-discoloring/). [Learn More](https://cedclinic.com/arizona-health-officials-recall-marijuana-preroll-over-possible-fungal-contamination/) [CBD Gummies News: What's Actually Worth Paying Attention To in 2026](https://cedclinic.com/cbd-gummies-news-what-s-actually-worth-paying-attention-to-in-2026/) Stay informed on the latest developments and safety considerations in the CBD gummies market for 2026. [Discover Insights](https://cedclinic.com/cbd-gummies-news-what-s-actually-worth-paying-attention-to-in-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).